Correlation Between Alphabet and Eterna Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alphabet and Eterna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Eterna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Eterna Therapeutics, you can compare the effects of market volatilities on Alphabet and Eterna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Eterna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Eterna Therapeutics.
Diversification Opportunities for Alphabet and Eterna Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Alphabet and Eterna is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Eterna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eterna Therapeutics and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Eterna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eterna Therapeutics has no effect on the direction of Alphabet i.e., Alphabet and Eterna Therapeutics go up and down completely randomly.
Pair Corralation between Alphabet and Eterna Therapeutics
Given the investment horizon of 90 days Alphabet Inc Class C is expected to generate 0.31 times more return on investment than Eterna Therapeutics. However, Alphabet Inc Class C is 3.26 times less risky than Eterna Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Eterna Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 13,944 in Alphabet Inc Class C on August 27, 2024 and sell it today you would earn a total of 2,713 from holding Alphabet Inc Class C or generate 19.46% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alphabet Inc Class C vs. Eterna Therapeutics
Performance |
| Timeline |
| Alphabet Class C |
| Eterna Therapeutics |
Alphabet and Eterna Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alphabet and Eterna Therapeutics
The main advantage of trading using opposite Alphabet and Eterna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Eterna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eterna Therapeutics will offset losses from the drop in Eterna Therapeutics' long position.The idea behind Alphabet Inc Class C and Eterna Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Eterna Therapeutics vs. Eliem Therapeutics | Eterna Therapeutics vs. HCW Biologics | Eterna Therapeutics vs. Scpharmaceuticals | Eterna Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |